Scope
Reference
DAC 20211
Description
This procurement is the manufacture and testing of over encapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial.
Contract 1. Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial
Supplier
Contract value
- £494,447.50 excluding VAT
- £593,337 including VAT
Above the relevant threshold
Award decision date
8 December 2025
Standstill period
- End: 17 December 2025
- 8 working days
Earliest date the contract will be signed
18 December 2025
Contract dates (estimated)
- 5 January 2026 to 5 January 2030
- 4 years, 1 day
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
ALMAC CLINICAL SERVICES LIMITED
- Companies House: NI041905
- Public Procurement Organisation Number: PRCD-2287-GMQG
Almac House
Craigavon
BT63 5QD
United Kingdom
Email: csrfinotifcations@almacgroup.com
Website: http://ww.almacgroup.com
Region: UKN07 - Armagh City, Banbridge and Craigavon
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland